Yoshiyuki Horio
Sapporo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Resveratrol promotes autophagosome elimination via SIRT1 in cardiomyocytes.
Journal: Journal of pharmacological sciences
Published: August 19, 2024
Resveratrol, a SIRT1 activator, attenuates aging-associated alterations in skeletal muscle and heart in mice.
Journal: Journal of pharmacological sciences
Published: November 14, 2022
SIRT1 in the cardiomyocyte counteracts doxorubicin-induced cardiotoxicity via regulating histone H2AX.
Journal: Cardiovascular research
Published: June 04, 2021
SIRT1 decelerates morphological processing of oligodendrocyte cell lines and regulates the expression of cytoskeleton-related oligodendrocyte proteins.
Journal: Biochemical and biophysical research communications
Published: January 15, 2021
Aging-associated inflammation and fibrosis in arachnoid membrane.
Journal: BMC neurology
Published: October 29, 2020
Different Antioxidative and Antiapoptotic Effects of Piceatannol and Resveratrol.
Journal: The Journal of pharmacology and experimental therapeutics
Published: May 11, 2020
SIRT1 deficiency interferes with membrane resealing after cell membrane injury.
Journal: PloS one
Published: January 25, 2019
Resveratrol Decreases Oxidative Stress by Restoring Mitophagy and Improves the Pathophysiology of Dystrophin-Deficient mdx Mice.
Journal: Oxidative medicine and cellular longevity
Published: July 05, 2018
Last Updated: 09/26/2026